Laboratory challenges in the diagnosis of hepatitis E virus

Journal of Medical Microbiology

Volumn 67, Issue 4, 2018, Pages 466-480

  Al Sadeq, Duaa W ^a   Majdalawieh, Amin F ^b   Mesleh, Areej G ^a   Abdalla, Omnya M ^a   Nasrallah, Gheyath K ^a,c  

^a Qatar University   (Qatar)

^b AMERICAN UNIVERSITY OF SHARJAH   (United Arab Emirates)

^c Qatar University   (Qatar)

Author keywords

Diagnosis; HEV; RNA viremia; Serology; Seroprevalence

Indexed keywords

VIRUS ANTIBODY; HEPATITIS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ANTIBODY DETECTION; DIAGNOSTIC ERROR; HEPATITIS E VIRUS; IMMUNOASSAY; LABORATORY DIAGNOSIS; MOLECULAR MECHANICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SEROLOGY; ANIMAL; BLOOD; GENETICS; GENOTYPE; HEPATITIS E; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; TRANSMISSION; VIROLOGY;

ANIMALS; ANTIGENS, VIRAL; DIAGNOSTIC ERRORS; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOASSAY; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 85045128127     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000706     Document Type: Review

References (150)

1. WHO Hepatitis E. www.who.int/mediacentre/factsheets/fs280/en/
2. CDC Viral Hepatitis -Hepatitis E Information. www.cdc.gov/hepatitis/hev/
3. WHO 2013; Regional strategy for the prevention and control of viral hepatitis. www.searo.who.int/entity/emerging_diseases/topics/CD_282.pdf
4. ICTV: Hepeviridae Study Group 2016; https://talk.ictvonline.org/ictv_wikis/hepeviridae
5. Emerson SU, Clemente-Casares P, Moiduddin N, Arankalle VA, Torian U et al. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol 2006;87: 697-704
6. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002;40: 4576-4580
7. Delarocque-Astagneau E, Abravanel F, Moshen A, Le Fouler L, Gad RR et al. Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. Clin Microbiol Infect 2012;18: 982-988
8. El-Sayed Zaki M, El-Deen Zaghloul MH, El Sayed O. Acute sporadic hepatitis E in children: diagnostic relevance of specific immunoglobulin M and immunoglobulin G compared with nested reverse transcriptase PCR. FEMS Immunol Med Microbiol 2006;48: 16-20
9. Centers for Disease Control and Prevention (CDC). Investigation of hepatitis E outbreak among refugees -Upper Nile, South Sudan, 2012-2013. MMWR Morb Mortal Wkly Rep 2013;62: 581
10. International Federation of Red Cross And Red Crescent Societies 2014; Uganda: Hepatitis E Virus disease outbreak DREF Operation n° MDRUG036-Emergency Plan of Action (EPoA) Final Report. http://reliefweb.int/report/uganda/uganda-hepatitis-e-virus-disease-outbreak-dref-operation-n-mdrug036-emergency-plan-0
11. Teshale EH, Grytdal SP, Howard C, Barry V, Kamili S et al. Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 2010;50: 1006-1010
12. Huang CC, Nguyen D, Fernandez J, Yun KY, Fry KE et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 1992;191: 550-558
13. Bi SL, Purdy MA, McCaustland KA, Margolis HS, Bradley DW. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res 1993;28: 233-247
14. Labrique AB, Thomas DL, Stoszek SK, Nelson KE. Hepatitis E: An emerging infectious disease. Epidemiol Rev 1999;21: 162-179
15. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-138
16. Cao D, Meng XJ. Molecular biology and replication of hepatitis E virus. Emerg Microbes Infect 2012;1:e17
17. Kantala T. Presence of hepatitis E virus (HEV) and markers for HEV infection in production swine, human patients with unexplained hepatitis, and veterinarians in Finland. Dissertationes Schola Doctoralis Scientiae Circumiectalis, Alimentarie, Biologicae. 2017;
18. Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M et al. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis 2014;20: 1044-1048
19. Rasche A, Saqib M, Liljander AM, Bornstein S, Zohaib A et al. Hepatitis E Virus Infection in Dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983-2015. Emerg Infect Dis 2016;22: 1249-1252
20. Woo PC, Lau SK, Teng JL, Cao KY, Wernery U et al. New Hepatitis E virus genotype in bactrian camels, Xinjiang, China, 2013. Emerg Infect Dis 2016;22: 2219-2221
21. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol 2013;10: 24-33
22. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E in pregnant women and children in Iran: a general overview. J Clin Transl Hepatol 2016;4: 269-276
23. El Sayed Zaki M, El Razek MM, El Razek HM. Maternal-fetal hepatitis E transmission: is it underestimated?. J Clin Transl Hepatol 2014;2: 117-123
24. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clin Infect Dis 2014;60: 96-99
25. Khuroo MS, Kamili S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK Pract 2006;13: 70-74
26. Hepatitis E https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-e
27. Blasco-Perrin H, Madden RG, Stanley A, Crossan C, Hunter JG et al. Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study. Aliment Pharmacol Ther 2015;42:574-581
28. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D et al. Transfusion-transmitted hepatitis E in a ‘nonhyperendemic’ country. Transfus Med 2006;16: 79-83
29. Colson P, Coze C, Gallian P, Henry M, de Micco P et al. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13: 648-649
30. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19: 778-784
31. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48: 1368-1375
32. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004;44: 934-940
33. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74: 563-572
34. Tamura A, Shimizu YK, Tanaka T, Kuroda K, Arakawa Y et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007;37: 113-120
35. Recommendations from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on measures to protect patients from acquiring hepatitis E virus via transfusion or transplantation. 2016; http://hospital.blood.co.uk/media/28794/sabto-recommendations-nov-2016.pdf
36. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503
37. Féray C, Pawlotsky JM, Roque-Afonso AM, Samuel D, Dhumeaux D. Should we screen blood products for hepatitis E virus RNA?. Lancet 2014;383: 218
38. Vollmer T, Knabbe C, Dreier J. Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors. J Clin Microbiol 2014;52: 2150-2156
39. Gupta E, Pandey P, Pandey S, Sharma MK, Sarin SK. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. J Clin Virol 2013;58: 374-377
40. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384: 1766-1773
41. Halbur PG, Kasorndorkbua C, Gilbert C, Guenette D, Potters MB et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 2001;39: 918-923
42. Billam P, Huang FF, Sun ZF, Pierson FW, Duncan RB et al. Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens. J Virol 2005;79: 3429-3437
43. Nan Y, Zhang YJ. Molecular biology and infection of hepatitis E virus. Front Microbiol 2016;7: 1419
44. Aggarwal R, Goel A. Advances in hepatitis E - I: virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol 2016;10: 1053-1063
45. Zhang F, Li X, Li Z, Harrison TJ, Chong H et al. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J Med Virol 2006;78: 1441-1448
46. Takahashi M, Yamada K, Hoshino Y, Takahashi H, Ichiyama K et al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch Virol 2008;153: 1703-1713
47. Aggarwal R, Kini D, Sofat S, Naik SR, Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000;356: 1081-1082
48. Geng Y, Zhao C, Huang W, Harrison TJ, Zhang H et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 2016;64: 37-43
49. Trémeaux P, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L et al. Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection. J Clin Virol 2016;79: 1-5
50. Park HK, Jeong SH, Kim JW, Woo BH, Lee DH et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis 2012;12: 142
51. Kmush BL, Labrique AB, Dalton HR, Ahmed ZB, Ticehurst JR et al. Two generations of “Gold Standards”: The impact of a decade in hepatitis E virus testing innovation on population seroprevalence. Am J Trop Med Hyg 2015;93: 714-717
52. Vernier M, Rossi-Tamisier M, Richet H, Brouqui P, Parola P et al. Anti-hepatitis E virus antibody prevalence in French expatriate workers. Int J Infect Dis 2013;17: e1082-4
53. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010;82:799-805
54. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarría JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol 2015;87:1934-1939
55. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol2013;58: 629-634
56. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013;58: 624-628
57. Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G et al. An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. PLoS One 2013;8:e62980
58. Sommerkorn FM, Schauer B, Schreiner T, Fickenscher H, Krumbholz A. Performance of hepatitis E virus (HEV)-antibody tests: a comparative analysis based on samples from individuals with direct contact to domestic pigs or wild boar in Germany. Med Microbiol Immunol 2017;206: 277-286
59. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992;36: 246-250
60. Herremans M, Duizer E, Jusic E, Koopmans MP. Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3. Clin Vaccine Immunol2007;14: 276-280
61. Zhang S, Tian D, Zhang Z, Xiong J, Yuan Q et al. Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM. Dig Dis Sci 2009;54: 2512-2518
62. Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 2005;43: 49-56
63. Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BP et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J Virol 1994;68: 7067-7074
64. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group. Hepatology 1998;27: 857-861
65. Lin CC, Wu JC, Chang TT, Chang WY, Yu ML et al. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol 2000;38: 3915-3918
66. Shrestha AC, Flower RL, Seed CR, Stramer SL, Faddy HM. A comparative study of assay performance of commercial hepatitis E virus enzyme-linked immunosorbent assay kits in Australian blood donor samples. J Blood Transfus 2016;2016: 1-6
67. Hyams C, Mabayoje DA, Copping R, Maranao D, Patel M et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol 2014;86: 478-483
68. Mikrogen recomLine HEV IgG/IgM. www.mikrogen.de/english/deutschland/products/product-overview/testsystem/hev-iggigm.html
69. Chen HY, Lu Y, Howard T, Anderson D, Fong PY et al. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera. Clin Diagn Lab Immunol 2005;12: 593-598
70. Legrand-Abravanel F, Thevenet I, Mansuy JM, Saune K, Vischi F et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009;16: 772-774
71. Myint KS, Guan M, Chen HY, Lu Y, Anderson D et al. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am J Trop Med Hyg2005;73: 942-946
72. Vollmer T, Diekmann J, Eberhardt M, Knabbe C, Dreier J. Monitoring of anti-hepatitis E virus antibody seroconversion in asymptomatically infected blood donors: systematic comparison of nine commercial anti-HEV IgM and IgG assays. Viruses 2016;8: 232
73. Yu C, Engle RE, Bryan JP, Emerson SU, Purcell RH. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol 2003;10: 579-586
74. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2013;207: 497-500
75. Kodani M, Kamili NA, Tejada-Strop A, Poe A, Denniston MM et al. Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E. J Med Virol 2017;89: 1055-1061
76. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2013;56: 62-64
77. Allain JP. Genomic screening for blood-borne viruses in transfusion settings. Clin Lab Haematol 2000;22: 1-10
78. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need?. Lancet 2014;384: 1729-1730
79. Chandnani M, Kaur M, Ramadhas A, Tumarinson T. A case report about the most common yet most forgotten hepatitis E. Am J Case Rep 2016;17: 584-586
80. Dawson GJ, Mushahwar IK, Chau KH, Gitnick GL. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan. Lancet 1992;340: 426-427
81. Nasrallah GK, Al Absi ES, Ghandour R, Ali NH, Taleb S et al. Seroprevalence of hepatitis E virus among blood donors in Qatar (2013-2016). Transfusion 2017;57: 1801-1807
82. Vollmer T, Diekmann J, Johne R, Eberhardt M, Knabbe C et al. Novel approach for detection of hepatitis E virus infection in German blood donors. J Clin Microbiol 2012;50: 2708-2713
83. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J et al. Seroprevalence and Incidence of hepatitis E in blood donors in upper Austria. PLoS One 2015;10: e0119576
84. Behrendt P, Bremer B, Todt D, Brown RJ, Heim A et al. Hepatitis E virus (HEV) ORF2 antigen levels differentiate between acute and chronic HEV infection. J Infect Dis 2016;214: 361-368
85. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010;16: 74-82
86. Coilly A, Haïm-Boukobza S, Roche B, Antonini TM, Pause A et al. Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Transplantation 2013;96: e4-e6
87. Sakata H, Matsubayashi K, Takeda H, Sato S, Kato T et al. A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008;48: 2568-2576
88. Guo QS, Yan Q, Xiong JH, Ge SX, Shih JW et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010;48: 317-318
89. Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ et al. Hepatitis E. Vox Sang 2016;110: 93-103
90. Adlhoch C, Kaiser M, Pauli G, Koch J, Meisel H. Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang 2009;97: 303-308
91. Ijaz S, Szypulska R, Tettmar KI, Kitchen A, Tedder RS. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2011;102: 272
92. Baylis SA, Gärtner T, Nick S, Ovemyr J, Blümel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang 2012;103: 89-90
93. Cleland A, Smith L, Crossan C, Blatchford O, Dalton HR et al. Hepatitis E virus in Scottish blood donors. Vox Sang 2013;105: 283-289
94. Corman VM, Drexler JF, Eckerle I, Roth WK, Drosten C et al. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang 2013;104: 179-180
95. Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F et al. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 2014;20: 1914-1917
96. Sauleda S, Ong E, Bes M, Janssen A, Cory R et al. Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015;55: 972-979
97. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003;112: 145-151
98. Tavares RG, Staggemeier R, Borges ALP, Rodrigues MT, Castelan LA et al. Molecular techniques for the study and diagnosis of parasite infection. J Venom Anim Toxins Incl Trop Dis 2011;17: 239-248
99. Gallarda JL, Dragon E. Blood screening by nucleic acid amplification technology: current issues, future challenges. Mol Diagn 2000;5: 11-22
100. Vyas GN, Yang G, Murphy EL. Transfusion-related transmissible diseases: detection by polymerase chain reaction-amplified genes of the microbial agents. Transfus Med Rev 1994;8: 253-266
101. Deepak S, Kottapalli K, Rakwal R, Oros G, Rangappa K et al. Real-Time PCR: revolutionizing detection and expression analysis of genes. Curr Genomics 2007;8: 234-251
102. Pripuzova N, Wang R, Tsai S, Li B, Hung GC et al. Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens. PLoS One 2012;7: e43246
103. Gerber PF, Xiao CT, Cao D, Meng XJ, Opriessnig T. Comparison of real-time reverse transcriptase PCR assays for detection of swine hepatitis E virus in fecal samples. J Clin Microbiol 2014;52: 1045-1051
104. Zhao Q, Xie S, Sun Y, Chen Y, Gao J et al. Development and evaluation of a SYBR Green real-time RT-PCR assay for detection of avian hepatitis E virus. BMC Vet Res 2015;11: 195
105. Stensvold CR, Ahmed UN, Andersen LO, Nielsen HV. Development and evaluation of a genus-specific, probe-based, internal-process-controlled real-time PCR assay for sensitive and specific detection of Blastocystis spp. J Clin Microbiol 2012;50: 1847-1851
106. Pestana E, Belak S, Diallo A, Crowther JR, Viljoen GJ et al. Early, Rapid and Sensitive Veterinary Molecular Diagnostics-Real Time PCR Applications Netherlands Springer Science & Business Media 2010
107. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J et al. The real-time polymerase chain reaction. Mol Aspects Med 2006;27: 95-125
108. Chhabra P, Vinjé J. Molecular detection methods of foodborne viruses. In Goyal S, Cannon J. (editors)Viruses in Foods Cham Springer 2016; pp. 303-333
109. Acquisition of CEERAM, specialized in the detection of foodborne viruses. www.biomerieux-industry.com/acquisition-ceeram-specialized-detection-foodborne-viruses
110. Pelosi E, Clarke I. Hepatitis E: a complex and global disease. Emerg Health Threats J 2008;1: e8
111. Nascimento MSJ, Abreu-Silva J, Teixeira J, Oliveira RMS, Mesquita JR et al. Seroprevalence of hepatitis E virus among the Portuguese general population and prevalence of silent infection in blood donors -HEPeCONTROL. J Clin Virol 2016;82: S14-S15
112. altona diagnostic 2016; RealStar® HEV RT-PCR Kit 1.0. www.altona-diagnostics.com/tl_files/website/downloads/RealStar%C2%AE%20HEV%20RT-PCR%20Kit%201.0_CE_RevS01_WEB.pdf
113. Juhl D, Baylis SA, Blümel J, Görg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion 2014;54: 49-56
114. Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H et al. International standard to harmonize assays for detection of hepatitis E virus RNA. 2013;
115. Baylis SA, Hanschmann KM, Blümel J, Nübling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011;49: 1234-1239
116. Eiken The principle of LAMP method. http://loopamp.eiken.co.jp/e/lamp/principle.html
117. Notomi T, Mori Y, Tomita N, Kanda H. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects. J Microbiol 2015;53: 1-5
118. Njiru ZK, Mikosza AS, Armstrong T, Enyaru JC, Ndung’u JM et al. Loop-mediated isothermal amplification (LAMP) method for rapid detection of Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 2008;2: e147
119. Meridian Bioscience LAMP technology - description of the lamp process. https://vimeo.com/13391184
120. Lan X, Yang B, Li BY, Yin XP, Li XR et al. Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus. J Clin Microbiol 2009;47: 2304-2306
121. Hologic 2017; Transcription Mediated Amplification (TMA). www.youtube.com/watch?v=qQQtq1LaGL8
122. Hologic 2018; www.hologic.com/hologic-products/diagnostic-solutions/instrumentation
123. Stramer SL, Moritz ED, Foster GA, Ong E, Linnen JM et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56: 481-488
124. Baylis SA, Corman VM, Ong E, Linnen JM, Nübling CM et al. Hepatitis E viral loads in plasma pools for fractionation. Transfusion 2016;56: 2532-2537
125. Shrestha AC, Flower RL, Seed CR, Keller AJ, Harley R et al. Hepatitis E virus RNA in Australian blood donations. Transfusion 2016;56: 3086-3093
126. O’Riordan J, Boland F, Williams P, Donnellan J, Hogema BM et al. Hepatitis E virus infection in the Irish blood donor population. Transfusion 2016;56: 2868-2876
127. Mikrogen ampliCube HEV 2.0. www.mikrogen.de/english/deutschland/nc/products/product-overview/testsystem/hev-20.html
128. Instructions for Use RealStar® HEV RT-PCR Kit 1.0. 2016; www.altona-diagnostics.com/tl_files/website/downloads/RealStar%C2%AE%20HEV%20RT-PCR%20Kit%201.0_CE_RevS01_WEB.pdf
129. La Rosa G, Fratini M, Muscillo M, Iaconelli M, Taffon S et al. Molecular characterisation of human hepatitis E virus from Italy: comparative analysis of five reverse transcription-PCR assays. Virol J 2014;11:72
130. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23: 2947-2948
131. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16: 5-36
132. World Health Organization. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review. 2010
133. Gad YZ, Mousa N, Shams M, Elewa A. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J Transfus Sci 2011;5: 136
134. Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med 2014;6: 45
135. Zhou H, Jiang CW, Li LP, Zhao CY, Wang YC et al. Comparison of the reliability of two ELISA kits for detecting IgM antibody against hepatitis E virus. Zhonghua Yu Fang Yi Xue Za Zhi 2008;42: 667-671
136. Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L et al. Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. J Clin Virol 2015;70: 101-104
137. Norder H, Karlsson M, Mellgren Å, Konar J, Sandberg E et al. Diagnostic performance of five assays for anti-hepatitis E virus IgG and IgM in a large cohort study. J Clin Microbiol 2016;54: 549-555
138. Drobeniuc J, Meng J, Reuter G, Greene-Montfort T, Khudyakova N et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010;51: e24-e27
139. Wu WC, Su CW, Yang JY, Lin SF, Chen JY et al. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. J Med Virol 2014;86: 720-728
140. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM et al. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol 2013;58: 624-628
141. Galiana C, Fernández-Barredo S, García A, Gómez MT, Pérez-Gracia MT. Occupational exposure to hepatitis E virus (HEV) in swine workers. Am J Trop Med Hyg 2008;78: 1012-1015
142. Schnegg A, Bürgisser P, André C, Kenfak-Foguena A, Canellini G et al. A comparison of three anti-HEV IgG EIA screening kits and one confirmatory immunodot assay in blood donor samples in Switzerland. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Francisco CA, USA 2012;
143. Yan Q, Du H-L, Wang Y-B, Ge S-X, Huang S-J et al. Comparison of two diagnostic reagents to detect anti-hepatitis E virus IgG antibodies. Chinese Journal of Zoonoses 2008;24: 1087-1089
144. Garg G, Kumar D, Asim M, Husain SA, das BC et al. Multiplex reverse transcriptase-PCR for simultaneous detection of hepatitis B, C, and E virus. J Clin Exp Hepatol 2016;6: 33-39
145. Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997;94: 9860-9865
146. Wu JC, Sheen IJ, Chiang TY, Sheng WY, Wang YJ et al. The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology 1998;27:1415-1420
147. Jothikumar N, Aparna K, Kamatchiammal S, Paulmurugan R, Saravanadevi S et al. Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction. Appl Environ Microbiol 1993;59: 2558-2562
148. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012;18: 869-872
149. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18: 20550
150. Abravanel F, Sandres-Saune K, Lhomme S, Dubois M, Mansuy JM et al. Genotype 3 diversity and quantification of hepatitis E virus RNA. J Clin Microbiol 2012;50: 897-902